Literature DB >> 17988192

Bioreactor for application of subatmospheric pressure to three-dimensional cell culture.

Robert P Wilkes1, Amy K McNulty, Teri D Feeley, Marisa A Schmidt, Kris Kieswetter.   

Abstract

Vacuum-assisted closure (VAC) negative pressure wound therapy (NPWT) is a highly successful and widely used treatment modality for wound healing, although no apparatus exists to monitor the effects of subatmospheric pressure application in vitro. Such an apparatus is desirable to better understand the biological effects of this therapy and potentially improve upon them. This article describes the development and validation of a novel bioreactor that permits such study. Tissue analogues consisting of 3-dimensional fibroblast-containing fibrin clots were cultured in off-the-shelf disposable cell culture inserts and multi-well plates that were integrated into the bioreactor module. Negative pressure dressings, commercialized for wound therapy, were placed on top of the culture, and subatmospheric pressure was applied to the dressing. Cultures were perfused with media at controlled physiologic wound exudate flow rates. The design of this bioreactor permits observation of the culture using an inverted microscope in brightfield and fluorescence modes and sustained incubation of the system in a 5% carbon dioxide atmosphere. This closed-system mimics the wound micro-environment under VAC NPWT. Matrix compression occurs as the subatmospheric pressure draws the dressing material down. At the contact zone, surface undulations were clearly evident on the fibroblast-containing tissue analogues at 24 h and appeared to correspond to the dressing microstructure. The bioreactor design, consisting of sterilizable machined plastics and disposable labware, can be easily scaled to multiple units. Validation experiments show that cell survival in this system is comparable with that seen in cells grown in static tissue culture. After application of VAC NPWT, cell morphology changed, with cells appearing thicker and with an organized actin cytoskeleton. The development and validation of this new culture system establishes a stable platform for in vitro investigations of subatmospheric pressure application to tissues.

Entities:  

Mesh:

Year:  2007        PMID: 17988192     DOI: 10.1089/ten.2007.0036

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  6 in total

1.  Microdeformation of three-dimensional cultured fibroblasts induces gene expression and morphological changes.

Authors:  Feng Lu; Rei Ogawa; Dinh T Nguyen; Bin Chen; Danfeng Guo; Douglas L Helm; Qian Zhan; George F Murphy; Dennis P Orgill
Journal:  Ann Plast Surg       Date:  2011-03       Impact factor: 1.539

2.  Enhancement of Bone-Marrow-Derived Mesenchymal Stem Cell Angiogenic Capacity by NPWT for a Combinatorial Therapy to Promote Wound Healing with Large Defect.

Authors:  Kangquan Shou; Yahui Niu; Xun Zheng; Zhanjun Ma; Chao Jian; Baiwen Qi; Xiang Hu; Aixi Yu
Journal:  Biomed Res Int       Date:  2017-01-24       Impact factor: 3.411

3.  Negative pressure wound therapy promotes muscle-derived stem cell osteogenic differentiation through MAPK pathway.

Authors:  Hong Liu; Xun Zheng; Liang Chen; Chao Jian; Xiang Hu; Yong Zhao; Zonghuan Li; Aixi Yu
Journal:  J Cell Mol Med       Date:  2017-09-25       Impact factor: 5.310

4.  The Role of Interstitial Fluid Pressure in Cerebral Porous Biomaterial Integration.

Authors:  Fabien Bonini; Sébastien Mosser; Flavio Maurizio Mor; Anissa Boutabla; Patrick Burch; Amélie Béduer; Adrien Roux; Thomas Braschler
Journal:  Brain Sci       Date:  2022-03-22

5.  Effects of negative pressure wound therapy on mesenchymal stem cells proliferation and osteogenic differentiation in a fibrin matrix.

Authors:  Jin Zhu; Aixi Yu; Baiwen Qi; Zonghuan Li; Xiang Hu
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

6.  A bioreactor for studying negative pressure wound therapy on skin grafts.

Authors:  Gabrielle Notorgiacomo; Justin Klug; Scott Rapp; Steven T Boyce; Stacey C Schutte
Journal:  Int Wound J       Date:  2021-07-07       Impact factor: 3.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.